Related Articles
β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms
The role of dual‑specificity phosphatase 1 and protein phosphatase 1 in β2‑adrenergic receptor‑mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines
Propranolol sensitizes thyroid cancer cells to cytotoxic effect of vemurafenib
Clinical outcome of brain metastases differs significantly among breast cancer subtypes
Effect and mechanism of propranolol on promoting osteogenic differentiation and early implant osseointegration